Status:

ACTIVE_NOT_RECRUITING

Project HOME: Home-Based Treatment Options and Mechanisms for Eating Disorders

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

Lifespan

Conditions:

Anorexia Nervosa

Eating Disorders

Eligibility:

All Genders

12-18 years

Phase:

NA

Brief Summary

This randomized, controlled effectiveness trial will assess outcomes, implementation, and mechanisms of two psychological treatments for adolescent anorexia nervosa (AN) delivered in the home setting,...

Detailed Description

Participants (adolescents with AN-spectrum and their parents) are asked to complete study assessments at 5 time points: baseline and 6-, 12-, 24-, and 32-weeks after starting treatment. The 32-week ti...

Eligibility Criteria

Inclusion

  • Meets criteria for AN or atypical AN according to DSM-5 diagnostic criteria.
  • Currently living at home with caregivers who are willing to engage in family treatment.
  • Medically stable for outpatient treatment according to the recommended thresholds of the American Academy of Pediatrics and the Society of Adolescent Medicine (e.g., ≥75% of expected body weight, heartrate ≥50 beats per minute) and receiving medical monitoring from a clinician throughout treatment.
  • If on psychotropic medication, meets all eligibility criteria while on stable dose of psychotropic medication for a co-morbid condition.
  • Available for follow-up.

Exclusion

  • Associated physical illness that necessitates hospitalization.
  • Psychotic illness/other mental illness requiring hospitalization.
  • Current dependence on drugs or alcohol.
  • Physical conditions (e.g. diabetes mellitus, pregnancy) known to influence eating or weight.
  • Concurrent involvement in other psychological treatment for an eating disorder.
  • Developmental delay that would preclude participation in the intervention.

Key Trial Info

Start Date :

August 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 30 2026

Estimated Enrollment :

77 Patients enrolled

Trial Details

Trial ID

NCT05184556

Start Date

August 1 2022

End Date

April 30 2026

Last Update

December 10 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15213

2

Gateway Healthcare

Pawtucket, Rhode Island, United States, 02860